Skip to main content

Together we are beating cancer

Donate now

Cancer Grand Challenges

Showing 12 out of 51 results
An elderly male patient sat on a hospital bed

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

by Jacob Smith | In depth | 29 May 2023

29 May 2023

Andrea receiving chemotherapy.

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

by Tim Gunn | In depth | 22 May 2023

22 May 2023

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

by Phil Prime | In depth | 10 March 2023

10 March 2023

A Cancer Grand Challenges graphic announcing 9 new challenges
  • Science & Technology
  • Health & Medicine

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

A cancer cell undergoing mitosis, or cloning itself and splitting in two.

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

by Tim Gunn | In depth | 20 February 2023

20 February 2023

A busy London street.

Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around. Cancer rates in adults under 50 have been rising since the 1990s. Our researchers are leading the effort to turn the trend around.

by Tim Gunn | In depth | 24 January 2023

24 January 2023

A man wearing a virtual reality headset

The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how. The same techniques that make video games so popular can help us treat cancer. Owen Harris, designer of a new VR tool for studying tumours, tells us how.

by Lilly Matson | In depth | 1 December 2022

1 December 2022

Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

This entry is part 2 of 2 in the series Inside Cancer Grand Challenges
Cancer Research UK researchers

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

by Jacob Smith | Analysis | 16 June 2022

16 June 2022

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges